Summary
This document is a fact sheet detailing IQVIA's Insights as a Service (IaaS), which provides enterprise-grade analytics specifically designed for biopharma companies. It outlines the challenges faced by biopharma brands, such as tight timelines and fragmented data, which complicate the acquisition of timely insights. IaaS aims to address these issues by offering a turnkey analytics foundation that integrates licensed datasets into a unified view, thereby eliminating data silos and accelerating decision-making. The document describes key capabilities of the IaaS solution, including the ability to track key performance indicators, optimize territory design, enhance patient retention, and improve payer strategies. It also highlights the modular architecture of IaaS, which allows for scalable and flexible deployment options. The implementation process is noted to typically take four to six weeks, with various modules available for customization. Overall, the document presents IaaS as a solution for biopharma organizations seeking to enhance their analytics capabilities and decision-making processes.
